Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released May 6, 2021, after the close
10-Q filed May 6, 2021, 36 days after period end · 0001564590-21-024997
| Metric | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|
| Net Income | -$16.51M | -$8.87M | -$6.02M |
| EPS Diluted | -$0.45 | -$4.46 | -$3.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2021 · filed May 6, 2021 · 36 d after period end
0.0% from the close of May 6, 2021 to the close of May 7, 2021, the first after the release.